Fidia Pharma

Fidia Pharma

Fabbricazione di prodotti farmaceutici

Abano Terme, PD 111.573 follower

Chi siamo

Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (HA) in joint care, skin care, eye care, aesthetic care and regenerative care. Nearly 60 years of R&D have placed Fidia at the forefront in the production of natural and functionalized HA, with different ranges of molecular weight (+1,200 patents). Manufacturing operations – located in Italy - are inspected and approved by major international health authorities, including the US and Korean FDA, the Brazilian ANVISA and G-MED Notified Body, and comply with the strictest international regulations and safety standards. Fidia extends its global reach through local partners in +100 countries worldwide, as well as wholly owned subsidiaries in USA, Germany, Austria, Spain, France, Russia, Czech Republic, Slovakia, Romania, Poland, Egypt and Middle East.

Sito Web
http://www.fidiapharma.com
Settore
Fabbricazione di prodotti farmaceutici
Dimensioni dell’azienda
1001 - 5000 dipendenti
Sede principale
Abano Terme, PD
Tipo
Società privata non quotata
Settori di competenza
Hyaluronan R&D and Production e Manufacturing of Pharmaceutical finished products

Località

Dipendenti presso Fidia Pharma

Aggiornamenti

  • Visualizza la pagina dell’organizzazione di Fidia Pharma, immagine

    111.573 follower

    At Fidia, we value connection and active listening. Which is why our President and CEO, Carlo Pizzocaro, hosts "Coffee with the CEO": regular meetings with new hires to foster fresh ideas and open dialogue. These sessions encourage two-way communication and help us view the company through new perspectives, promoting a collaborative work environment based on trust and openness. #WeAreFidia #EvolvingWithFidia

    Visualizza il profilo di Carlo Pizzocaro, immagine

    President & CEO presso Fidia Pharma

    In an increasingly competitive labour market, a distinctive element for successful companies is the ability to actively listen to their employees. Active listening is not just a managerial skill, it is a real strategic tool for retaining existing employees and attracting new talent.   Whenever the opportunity arises, I invite everyone who works at Fidia to reflect on the importance of listening and having the courage to speak up and take the initiative. I do this in my regular meetings with new recruits, during which I ask them to share their impressions of the company; ‘Fresh’ eyes can help us not only to (re)interpret our situation, but also to share the importance of two-way communication right from the start.   This is a unique opportunity that allows me to look at the Company with different eyes and measure the concrete changes and progress we are making, promoting a collaborative working environment.   ---   In un mercato del lavoro sempre più competitivo, un elemento distintivo per le aziende di successo è la capacità di ascoltare attivamente i propri collaboratori. L'ascolto attivo non è solo una competenza manageriale, ma un vero e proprio strumento strategico per mantenere i talenti esistenti e attrarne di nuovi. Ogniqualvolta se ne presenti l'occasione invito tutte le persone che lavorano in Fidia a riflettere sull'importanza dell'ascolto e sul coraggio di parlare e prendere l’iniziativa. Lo faccio negli incontri che periodicamente ho con le persone neo-assunte durante i quali chiedo loro di esprimere le proprie impressioni sull'Azienda; occhi “nuovi” ci possono aiutare non solo a (ri)leggere il nostro contesto ma anche a condividere già dai primi giorni l’importanza di una comunicazione bi-direzionale. Un'opportunità unica che mi permette di guardare l'Azienda con occhi diversi e misurare i cambiamenti concreti e i progressi che stiamo facendo, promuovendo un ambiente di lavoro collaborativo.

    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Fidia Pharma, immagine

    111.573 follower

    At Fidia, we believe that investing in Our People is key to building a successful future. We collaborated with CUOA Business School, a trusted partner, to create an intensive training program for our Product Managers, running from March to June. This initiative is designed to empower individuals with the latest marketing strategies and skills. The comprehensive program aims to establish a common foundation, equipping our team with the tools and knowledge needed to excel in the dynamic world of marketing. Together, we are building a brighter future. #WeAreFidia #EvolvingWithFidia #CUOABusinessSchool Michela Rossetto, MBA Nora Sperotto Francesca Sala Ilaria Pajola

    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Fidia Pharma, immagine

    111.573 follower

    Our #EyeCare team has just arrived in Madrid for the European Dry Eye Society Congress 2024. 📍 Join us tomorrow at our symposium: “Sailing between Scylla and Charybdis: targeting Dry Eye Disease personalized treatment”, from 13:45 - 14:45 in Room 1 It will be an exciting opportunity for scientific discussion and professional exchange among ophthalmology specialists. We look forward to meeting you at out Fidia booth at the Hotel RIU Plaza España. See you this weekend! #EyeCare #EuDEC #EuDEC2024 #EuDES

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Fidia Pharma, immagine

    111.573 follower

    The Isokinetic Conference, the largest international conference on Football Medicine, has come to an end.   We always stand by athletes around the world and are proud to have been part of the conference also this year.   A big thank you to all #FidiaPeople who attended and to all those who came to visit us at our booth. #JointCare #RegenerativeCare #Isokinetic #Isokinetic2024 Isokinetic Conference Isokinetic Medical Group

    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
      + 1
  • Visualizza la pagina dell’organizzazione di Fidia Pharma, immagine

    111.573 follower

    We are proud to announce the finalization of an agreement for a significant new strategic acquisition that will allow us to decisively accelerate the internationalization process already underway. We continue to grow! This agreement represents our third operation in the first months of 2024 following the recent acquisitions and commercial agreements in the Italian market.   These operations are part of a double-digit organic growth trend, demonstrated by our recently announced 2023 financial statements that are once again positive, with a turnover of 463,5 million euros (+12,5% compared to 2022). Find out more in our press release at the following link: https://lnkd.in/eySzT8St

  • Visualizza la pagina dell’organizzazione di Fidia Pharma, immagine

    111.573 follower

    🙏 Reflecting on a successful Fidia Eye Care Academy Recently we invited ophthalmologists from across Europe and the META region to explore the latest updates and techniques in #EyeCare. From in-depth discussions on managing dry eye disease, glaucoma, and keratoconus to immersive workshops and wet labs, every moment was full of learning and collaboration. It was an opportunity to present our new Real-World Data (RWD) and Real-World Evidence (RWE) trial on keratoconus just starting in 6 countries. Thank you to all our participants, speakers, and moderators! It was a pleasure exchanging insights and shaping the future of #EyeCare together.

Pagine simili

Sfoglia le offerte di lavoro